Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESO-CAR T Cells for Relapsed/Refractory Epithelial Ovarian Cancer
NCT03916679Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of anti-mesothelin CAR-T cells in epithelial ovarian cancer (EOC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
anti-mesothelin CAR-T cells
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT03916679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916679.